These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12000000

  • 1. Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients.
    Tukiainen H, Rytilä P, Hämäläinen KM, Silvasti MS, Keski-Karhu J, Finnish Study Group.
    Respir Med; 2002 Apr; 96(4):221-9. PubMed ID: 12000000
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two budesonide dry powder inhalers in the treatment of asthma in children.
    Vanto T, Hämäläinen KM, Vahteristo M, Wille S, Njå F, Hyldebrandt N, Study Group.
    J Aerosol Med; 2004 Apr; 17(1):15-24. PubMed ID: 15120009
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two budesonide powder inhalers, Easyhaler and Turbuhaler, in steroid-naïve asthmatic patients.
    Schweisfurth H, Malinen A, Koskela T, Toivanen P, Ranki-Pesonen M, German Study Group.
    Respir Med; 2002 Aug; 96(8):599-606. PubMed ID: 12195841
    [Abstract] [Full Text] [Related]

  • 4. Assessment of the systemic effects of budesonide inhaled from Easyhaler and from Turbuhaler in healthy male volunteers.
    Hämäläinen KM, Granander M, Toivanen P, Malinen A.
    Respir Med; 2001 Nov; 95(11):863-9. PubMed ID: 11716199
    [Abstract] [Full Text] [Related]

  • 5. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
    Lähelmä S, Kirjavainen M, Kela M, Herttuainen J, Vahteristo M, Silvasti M, Ranki-Pesonen M.
    Br J Clin Pharmacol; 2005 Feb; 59(2):167-73. PubMed ID: 15676038
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group.
    Miyamoto T, Takahashi T, Nakajima S, Makino S, Yamakido M, Mano K, Nakashima M, Tollemar U, Selroos O.
    Respirology; 2000 Sep; 5(3):247-56. PubMed ID: 11022987
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 Sep; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Japanese Pulmicort Turbuhaler study group.
    Miyamoto T, Takahashi T, Nakajima S, Makino S, Yamakido M, Mano K, Nakashima M, Tollemar U, Selroos O.
    Respirology; 2000 Sep; 5(3):231-40. PubMed ID: 11022985
    [Abstract] [Full Text] [Related]

  • 9. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG, Mendelson LM, Pearlman DS.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients.
    Hirst PH, Bacon RE, Pitcairn GR, Silvasti M, Newman SP.
    Respir Med; 2001 Sep; 95(9):720-7. PubMed ID: 11575892
    [Abstract] [Full Text] [Related]

  • 11. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH, Howland WC, Lumry WR.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [Abstract] [Full Text] [Related]

  • 12. Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma.
    Banov C, Howland WC, Lumry WR, Parasuraman B, Uryniak T, Liljas B.
    Allergy Asthma Proc; 2003 Jun; 24(2):129-36. PubMed ID: 12776447
    [Abstract] [Full Text] [Related]

  • 13. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group.
    Nelson HS, Bernstein IL, Fink J, Edwards TB, Spector SL, Storms WW, Tashkin DP.
    Chest; 1998 May; 113(5):1264-71. PubMed ID: 9596304
    [Abstract] [Full Text] [Related]

  • 14. Assessment of adrenal suppression from two new dry powder inhaler formulations of budesonide delivered by Clickhaler compared with the Pulmicort Turbuhaler.
    Kirkpatrick C, Buck H, Ellis S.
    J Aerosol Med; 2003 May; 16(1):31-6. PubMed ID: 12737682
    [Abstract] [Full Text] [Related]

  • 15. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.
    Busse WW, Chervinsky P, Condemi J, Lumry WR, Petty TL, Rennard S, Townley RG.
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):457-63. PubMed ID: 9564797
    [Abstract] [Full Text] [Related]

  • 16. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids.
    Metzger WJ, Hampel FC, Sugar M.
    J Asthma; 2002 Feb; 39(1):65-75. PubMed ID: 11883741
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
    Virchow JC, Rodriguez-Roisin R, Papi A, Shah TP, Gopalan G.
    BMC Pulm Med; 2016 Mar 17; 16():42. PubMed ID: 26987997
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
    Morice A, Das S, Ellis S, Trumpet Study Group.
    J Asthma; 2005 Oct 17; 42(8):697-703. PubMed ID: 16266962
    [Abstract] [Full Text] [Related]

  • 19. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J.
    Eur Respir J; 1996 Nov 17; 9(11):2263-72. PubMed ID: 8947070
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
    Toogood JH, White FA, Baskerville JC, Fraher LJ, Jennings B.
    J Allergy Clin Immunol; 1997 Feb 17; 99(2):186-93. PubMed ID: 9042043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.